Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Dec 31, 2014 powchik peter Officer Option Execute 25,000 52.03
Dec 24, 2014 sanofi Beneficial Owner (10% or more) Buy 30,002 392.72 - 399.74
Dec 23, 2014 sanofi Beneficial Owner (10% or more) Buy 171,457 384.43 - 398.16
Dec 19, 2014 powchik peter Officer Option Execute 3,264 30.63
Dec 18, 2014 van plew daniel p Officer Option Execute 3,264 30.63
Dec 17, 2014 mccorkle douglas s Officer Option Execute 2,800 30.63
Dec 16, 2014 goldberg murray a Officer Option Execute 3,264 30.63
Dec 16, 2014 mccorkle douglas s Officer Sell 943 410.00
Dec 16, 2014 mccorkle douglas s Officer Automatic Sell 5,875 410.00
Dec 16, 2014 mccorkle douglas s Officer Option Execute 6,818 30.63 - 52.03
Dec 16, 2014 stahl neil Officer Option Execute 3,264 30.63
Dec 16, 2014 yancopoulos george Officer Disposition (Non Open Market) 3,264 n/a
Dec 16, 2014 yancopoulos george Officer Acquisition (Non Open Market) 3,264 n/a
Dec 16, 2014 yancopoulos george Officer Option Execute 3,264 30.63
Dec 15, 2014 mccorkle douglas s Officer Automatic Sell 1,668 410.16 - 417.34
Dec 15, 2014 mccorkle douglas s Officer Option Execute 1,668 30.63
Nov 25, 2014 poon christine a Director Buy 400 410.00
Nov 24, 2014 brown michael s Director Disposition (Non Open Market) 2,000 n/a
Nov 24, 2014 gilman alfred g Director Sell 40,000 405.65 - 411.06
Nov 24, 2014 gilman alfred g Director Option Execute 40,000 24.41 - 57.11
Showing 41-60 of 933 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)